Management of Cushing's disease: outcome in patients with microadenoma detected on pituitary magnetic resonance imaging

被引:96
作者
Prevedello, Daniel M. [1 ]
Pouratian, Nader [2 ]
Sherman, Jonathan [2 ]
Jane, John A. [2 ]
Vance, Mary Lee [3 ]
Lopes, M. Beatriz [4 ]
Laws, Edward R., Jr. [5 ]
机构
[1] Univ Pittsburgh, Sch Med, Dept Neurol Surg, Pittsburgh, PA 15261 USA
[2] Univ Virginia Hlth Syst, Dept Neurosurg, Charlottesville, VA USA
[3] Univ Virginia Hlth Syst, Dept Internal Med, Div Endocrinol, Charlottesville, VA USA
[4] Univ Virginia Hlth Syst, Dept Pathol, Charlottesville, VA USA
[5] Stanford Univ, Med Ctr, Dept Neurosurg, Palo Alto, CA 94304 USA
关键词
Cushing's disease; microadenoma; pituitary adenoma; transsphenoidal approach;
D O I
10.3171/JNS/2008/109/10/0751
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Object. Outcomes of therapy for Cushing's disease (CD) vary depending oil different aspects of presentation and diagnostic studies. The authors designed this Study to verify the remission rate and outcomes after transsphenoidal surgery (TSS) for patients with CD who had positive findings on MR imaging. Methods. Patients who had presented with CD at the University of Virginia for initial treatment between July 1992 and December 2005 were retrospectively reviewed. The patients included in the study were considered to be optimal surgical candidates, defined as an adult (> 18 years of age) with classic clinical features of CD, laboratory Studies confirming a central (pituitary/hypothalamic) adrenocorticotropic hormone-dependent Source of disease, and ail MR imaging Study revealing a microadenoma in the sella turcica. Results. A total of 167 patients fulfilled the criteria. Thirty were men (18%) and 137 were women (82%). The mean age was 42.3 years (range 18.2-77 years). All patients underwent TSS. Surgical remission was achieved in 148 patients (88.6%), which was correlated with the Surgeon's intraoperative identification of all adenoma (p = 0.03). Histopathological confirmation of an adrenocorticotropic hormone-secreting adenoma strongly correlated with remission (p = 0.0001). Three patients (1.8%) had postoperative cerebrospinal fluid leaks. and I patient had meningitis. Transient diabetes insipidus was diagnosed and treated in 10 patients (6%), whereas permanent diabetes insipidus Occurred in 8 patients (4.8%). Panhypopituitarism followed the Surgery in 14 patients (8.3%), 13 of whom underwent total hypophysectomy (9 initially and 4 with early reoperations), and in I of 10 patients who underwent subtotal hypophysectomy. Nineteen patients (12.8%) who were initially in remission developed recurrent CD after all average of 50 months. The mean follow-up for the 167 patients was 39 months (range 6-157 months). Gamma Knife surgery was the most common modality of radiotherapy used to treat 3 1 patients ( 18.5%) who did not achieve remission or later presented With recurrent disease. Bilateral adrenalectomies were performed in 10 patients ill the series (6%), 2 of whom developed Nelson's syndrome. The overall posttreatment remission rate was 95.8%. Conclusions. Even in patients with ideal diagnostic criteria of CD, there remain a significant number of cases in which TSS alone is not adequate to assure long-lasting remission. A multidisciplinary approach is essential to the achievement of satisfactory overall remission rates.
引用
收藏
页码:751 / 759
页数:9
相关论文
共 46 条
[1]   Diagnosis and complications of Cushing's syndrome: A consensus statement [J].
Arnaldi, G ;
Angeli, A ;
Atkinson, AB ;
Bertagna, X ;
Cavagnini, F ;
Chrousos, GP ;
Fava, GA ;
Findling, JW ;
Gaillard, RC ;
Grossman, AB ;
Kola, B ;
Lacroix, A ;
Mancini, T ;
Mantero, F ;
Newell-Price, J ;
Nieman, LK ;
Sonino, N ;
Vance, ML ;
Giustina, A ;
Boscaro, M .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (12) :5593-5602
[2]   A CRITICAL-EVALUATION OF TRANSSPHENOIDAL PITUITARY SURGERY IN THE TREATMENT OF CUSHINGS-DISEASE - PREDICTION OF OUTCOME [J].
ARNOTT, RD ;
PESTELL, RG ;
MCKELVIE, PA ;
HENDERSON, JK ;
MCNEILL, PM ;
ALFORD, FP .
ACTA ENDOCRINOLOGICA, 1990, 123 (04) :423-430
[3]   Long-term remission rates after pituitary surgery for Cushing's disease: the need for long-term surveillance [J].
Atkinson, AB ;
Kennedy, A ;
Wiggam, MI ;
McCance, DR ;
Sheridan, B .
CLINICAL ENDOCRINOLOGY, 2005, 63 (05) :549-559
[4]   Treatment of Cushing's disease by transsphenoidal, pituitary microsurgery: Prognosis factors and long-term follow-up [J].
Bakiri, F ;
Tatai, S ;
Aouali, R ;
Semrouni, M ;
Derome, P ;
Chitour, F ;
Benmiloud, M .
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 1996, 19 (09) :572-580
[5]   Assessment of cure and recurrence after pituitary surgery for Cushing's disease [J].
Barbetta, L ;
Dall'Asta, C ;
Tomei, G ;
Locatelli, M ;
Giovanelli, M ;
Ambrosi, B .
ACTA NEUROCHIRURGICA, 2001, 143 (05) :477-482
[6]   Transsphenoidal surgery for pituitary tumors in the United States, 1996-2000: Mortality, morbidity, and the effects of hospital and surgeon volume [J].
Barker, FG ;
Klibanski, A ;
Swearingen, B .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (10) :4709-4719
[7]  
BOCHICCHIO D, 1995, J CLIN ENDOCR METAB, V80, P3114, DOI 10.1210/jc.80.11.3114
[8]   Improved diagnostic accuracy of inferior petrosal sinus sampling over imaging for localizing pituitary pathology in patients with Cushing's disease [J].
Booth, GL ;
Redelmeier, DA ;
Grosman, H ;
Kovacs, K ;
Smyth, HS ;
Ezzat, S .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1998, 83 (07) :2291-2295
[9]   Transsphenoidal microsurgical treatment of Cushing disease: postoperative assessment of surgical efficacy by application of an overnight low-dose dexamethasone suppression test [J].
Chen, JCT ;
Amar, AP ;
Choi, S ;
Singer, P ;
Couldwell, WT ;
Weiss, MH .
JOURNAL OF NEUROSURGERY, 2003, 98 (05) :967-973
[10]   Complications of transsphenoidal surgery: Results of a national survey, review of the literature, and personal experience [J].
Ciric, I ;
Ragin, A ;
Baumgartner, C ;
Pierce, D .
NEUROSURGERY, 1997, 40 (02) :225-236